As of 2025-04-19, the Relative Valuation of Sana Biotechnology Inc (SANA) is (21.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.65 USD, the upside of Sana Biotechnology Inc based on Relative Valuation is -1395.1%.
The range of the Relative Valuation is (19.44) - (21.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.4x - 22.2x | 19.3x |
| Forward P/E multiples | 15.3x - 18.2x | 16.8x |
| Fair Price | (19.44) - (21.58) | (21.37) |
| Upside | -1278.3% - -1407.6% | -1395.1% |
| Date | P/E |
| 2025-04-17 | -1.39 |
| 2025-04-16 | -1.33 |
| 2025-04-15 | -1.43 |
| 2025-04-14 | -1.53 |
| 2025-04-11 | -1.48 |
| 2025-04-10 | -1.29 |
| 2025-04-09 | -1.31 |
| 2025-04-08 | -1.13 |
| 2025-04-07 | -1.29 |
| 2025-04-04 | -1.25 |
| 2025-04-03 | -1.16 |
| 2025-04-02 | -1.37 |
| 2025-04-01 | -1.27 |
| 2025-03-31 | -1.42 |
| 2025-03-28 | -1.44 |
| 2025-03-27 | -1.56 |
| 2025-03-26 | -1.53 |
| 2025-03-25 | -1.81 |
| 2025-03-24 | -2.04 |
| 2025-03-21 | -1.95 |
| 2025-03-20 | -1.91 |
| 2025-03-19 | -1.97 |
| 2025-03-18 | -1.92 |
| 2025-03-17 | -2.34 |
| 2025-03-14 | -2.47 |
| 2025-03-13 | -2.24 |
| 2025-03-12 | -2.46 |
| 2025-03-11 | -2.32 |
| 2025-03-10 | -2.13 |
| 2025-03-07 | -2.18 |
| 2025-03-06 | -2.15 |
| 2025-03-05 | -2.15 |
| 2025-03-04 | -2.16 |
| 2025-03-03 | -2.05 |
| 2025-02-28 | -2.20 |
| 2025-02-27 | -2.18 |
| 2025-02-26 | -2.20 |
| 2025-02-25 | -2.18 |
| 2025-02-24 | -2.43 |
| 2025-02-21 | -2.54 |
| 2025-02-20 | -2.58 |
| 2025-02-19 | -2.61 |
| 2025-02-18 | -2.55 |
| 2025-02-14 | -2.67 |
| 2025-02-13 | -2.37 |
| 2025-02-12 | -2.40 |
| 2025-02-11 | -2.32 |
| 2025-02-10 | -2.31 |
| 2025-02-07 | -2.52 |
| 2025-02-06 | -2.75 |